Envoy Medical, Inc. (COCH)
(Delayed Data from NSDQ)
$1.31 USD
-0.06 (-4.38%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.29 -0.02 (-1.53%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
COCH 1.31 -0.06(-4.38%)
Will COCH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for COCH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COCH
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) Reports Q3 Loss, Lags Revenue Estimates
COCH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Orthofix (OFIX) Q3 Earnings Surpass Estimates
Masimo (MASI) Q3 Earnings and Revenues Top Estimates
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates
Other News for COCH
Is COCH positioned for a breakdown? 180 Bearish Setup shows up after sliding 4.38%
Is COCH building bearish momentum? Non-ADX 1,2,3,4 Bearish shows up after rising 3.79%
Envoy Medical Secures European Patent for Cochlear Implant
Shooting Star Candlestick appears for COCH after 1.49% move
Is COCH ready to make a move? NR7 shows up after rising 0.75%